GMPriority Pharma

Contract Manufactured Liposomal Products

Controlled development and manufacture of liposomal systems for commercial-scale

Specialist Manufacture of Advanced Liposomal Systems

GMPriority Pharma provides contract manufacturing for liposomal formulations, supporting partners from process definition through to commercial-scale batch production.

Operating within GMP-certified, FSSC ISO 22000-accredited UK facilities, we align formulation, processing and manufacturing conditions to ensure consistent, scalable output.

From formulation to manufacturable system

Successful liposomal products depend not only on formulation design, but on how those systems are translated into controlled manufacturing processes.

GMPriority Pharma structures contract manufacturing programmes to ensure alignment between:

  • Formulation composition
  • Processing parameters
  • Production environments

This integrated approach reduces scale-up risk and supports consistent performance across commercial batches.

A structured approach to contract manufacturing

GMPriority Pharma delivers contract manufacturing programmes through a defined integrated model spanning development, scale-up and commercial production.

Rather than separating formulation and manufacture, our approach ensures systems are designed, evaluated and produced within controlled operational frameworks from the outset.

  • Formulation assessment and optimisation
  • Process parameter definition (e.g. temperature, mixing, energy input)
  • Scale-up under real manufacturing constraints
  • Pilot batch production
  • Commercial manufacturing and ongoing supply

Each stage is designed to minimise variability and support reproducible manufacturing outcomes.

From Development to Repeatable Manufacture

Many liposomal systems perform under laboratory conditions but fail during scale-up due to uncontrolled variables and process sensitivity.

GMPriority Pharma addresses this by:

  • Evaluating formulation behaviour under real processing conditions
  • Identifying scale-dependent constraints early
  • Defining parameters aligned with manufacturing equipment

This ensures smoother transition from development into commercial production, reducing the need for reformulation.

Contract Manufacturing Capabilities

  • Liposomal encapsulation of partner formulations
  • Liquid and dry-format manufacturing
  • Process-defined scale-up and batch production
  • Integration with partner supply chains
  • Ongoing manufacturing and supply support

Designed for scale from the outset → Structured, repeatable production

Why Contract Manufacture?

Contract manufacturing is suited to:

  • Brands with proprietary formulations requiring specialist liposomal production
  • Formulators developing lipid-based delivery systems
  • Ingredient companies developing advanced encapsulated formats
  • Organisations requiring controlled, reproducible manufacturing environments
  • Companies scaling from pilot to commercial production

Built for Scale & Reproducibility

Launch your product with confidence

GMPriority Pharma’s white label programmes provide a structured, controlled route to market, combining delivery science, manufacturing discipline and commercial readiness.

Finished products are developed with commercial manufacture in mind from the outset. 

GMPriority Pharma focuses on formulation robustness, process transfer and batch-to-batch consistency, delivering products which can be manufactured reliably as volumes grow.

Scale-up is approached as a controlled extension of development logic, not as a reformulation exercise.

We support:

  • Defined batch parameters
  • Equipment compatibility
  • Process documentation
  • Reproducibility across production cycles.

This is particularly important for partners operating within regulated or quality-sensitive markets.

How We Engage

Our objective is to establish controlled, repeatable liposomal manufacturing programmes aligned with partner requirements and regulatory frameworks.

Engagement typically begins with:

Technical review of formulation requirements

Assessment of compatibility with liposomal processing

Agreement and alignment of production expectations

Defined manufacturing and quality framework

Contact us

Bring your formulation to commercial scale.

GMPriority Pharma provides the structure, control and manufacturing capability required to translate liposomal formulations into reliable commercial products.

Start your Project